Puma Biotechnology | PBYI - 売上原価





売上原価 変化する 日付
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Amgen USD 1.87B 271M 2026-06
Biogen USD 945.1M 147.6M 2026-06
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Daiichi Sankyo JPY 124.29B 6.02B 2026-06
Exelixis USD 20.66M 704K 2026-06
Gilead Sciences USD 1000M 445M 2026-06
Glaxosmithkline GBP 1.88B 1.6B 2026-03
Incyte USD 104.96M 457K 2026-06
MacroGenics USD 9.53M 585K 2026-03
Moderna USD 93M 862M 2026-06
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.09B 498M 2026-06
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
Takeda JPY 517.6B 42.94B 2026-06
TG Therapeutics USD 41.19M 7.68M 2026-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06